Literature DB >> 24595519

Correlations between A1c, fasting glucose, 2h postload glucose, and β-cell function in the Chinese population.

Cuiliu Li1, Huijie Yang, Guoyu Tong, Shanmei Shen, Wenhuan Feng, Yan Bi, Dalong Zhu.   

Abstract

This study was aimed to assess the associations of hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and 2h postload plasma glucose (2hPG) with β-cell function in the Chinese population. A total of 913 subjects underwent 75-g oral glucose tolerance test (OGTT) and HbA1c testing. According to OGTT, isolated impaired fasting glucose (i-IFG) was defined as 5.6 mmol/l ≤ FPG < 7.0 mmol/l and 2hPG < 7.8 mmol/l; isolated impaired glucose tolerance (i-IGT) was defined as FPG < 5.6 mmol/l and 7.8 mmol/l ≤ 2hPG < 11.1 mmol/l. HbA1c 5.7-6.4 % was used to identify subjects with prediabetes. Insulin release was calculated by basal homeostasis model assessment of insulin secretion (HOMA-β), early-phase InsAUC30/GluAUC30, and total-phase InsAUC120/GluAUC120. β-cell function relative to insulin sensitivity was expressed as disposition index (DI). All indices of insulin sensitivity and β-cell function gradually decreased with increasing HbA1c, FPG, and 2hPG (all p < 0.01). β-cell function decreased precipitously when HbA1c exceeded 5.5 %. Compared with HbA1c, FPG showed stronger correlations with HOMA-β, InsAUC30/GluAUC30, InsAUC120/GluAUC120, DI30, and DI120 (all p < 0.05), and 2hPG was more closely related to DI30 and DI120 (all p < 0.01). Moreover, FPG was more strongly related to HOMA-β and InsAUC30/GluAUC30 than 2hPG (all p < 0.05). The combination of i-IFG and HbA1c 5.7-6.4 % showed the greatest reduction in DI30 and DI120 compared with HbA1c 5.7-6.4 % alone, i-IGT, or i-IFG (p < 0.05). In conclusion, HbA1c could be used as a marker to identify subjects with impaired β-cell function, but OGTT performs better than HbA1c. The combination of HbA1c and FPG is a simple and sensitive method to evaluate β-cell function.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24595519     DOI: 10.1007/s00592-014-0563-5

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  4 in total

1.  Dichotomy in the Impact of Elevated Maternal Glucose Levels on Neonatal Epigenome.

Authors:  Ives Yubin Lim; Xinyi Lin; Ai Ling Teh; Yonghui Wu; Li Chen; Menglan He; Shiao-Yng Chan; Julia L MacIsaac; Jerry K Y Chan; Kok Hian Tan; Mary Foong Fong Chong; Michael S Kobor; Keith M Godfrey; Michael J Meaney; Yung Seng Lee; Johan G Eriksson; Peter D Gluckman; Yap Seng Chong; Neerja Karnani
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

2.  An affordable approach to classifying type 2 diabetes based on fasting plasma glucose, TyG index and BMI: a retrospective cohort study of NHANES Data from 1988 to 2014.

Authors:  Jing Xie; Xin Zhang; Hua Shao; Shenqi Jing; Tao Shan; Yaxiang Shi; Yong Li; Yun Liu; Naifeng Liu
Journal:  Diabetol Metab Syndr       Date:  2022-08-10       Impact factor: 5.395

3.  Serum Pigment Epithelium-Derived Factor Levels are Associated with Estradiol and Decrease After Adjusting for Alanine Aminotransferase in Chinese Women Based on Multiple Linear Regression Analysis.

Authors:  Cuiliu Li; Yunna Zhang; Fang Gao
Journal:  Diabetes Metab Syndr Obes       Date:  2022-09-23       Impact factor: 3.249

4.  Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial.

Authors:  Ting-Ting Yin; Yan Bi; Ping Li; Shan-Mei Shen; Xiao-Lu Xiong; Li-Jun Gao; Can Jiang; Yan Wang; Wen-Huan Feng; Da-Long Zhu
Journal:  Diabetes Ther       Date:  2018-05-09       Impact factor: 2.945

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.